US8124759B2
(en)
|
2007-05-09 |
2012-02-28 |
Abbott Laboratories |
Inhibitors of protein kinases
|
DK2155758T3
(da)
*
|
2007-05-10 |
2012-11-05 |
Biocryst Pharm Inc |
Tetrahydrofuro[3,4-d]dioxolanforbindelser til anvendelse i behandlingen af virusinfektioner og cancer
|
TW200942243A
(en)
*
|
2008-03-05 |
2009-10-16 |
Biocryst Pharm Inc |
Antiviral therapeutic agents
|
US20090247750A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Biocryst Pharmaceuticals, Inc. |
Process for preparing nucleoside analogs
|
PT2268642E
(pt)
|
2008-04-23 |
2015-06-02 |
Gilead Sciences Inc |
Análogos de carba-nulceósidos 1¿-substituídos para tratamento antiviral
|
EP2313102A2
(en)
|
2008-07-03 |
2011-04-27 |
Biota Scientific Management |
Bycyclic nucleosides and nucleotides as therapeutic agents
|
ES2453078T3
(es)
|
2009-02-10 |
2014-04-03 |
Gilead Sciences, Inc. |
Análogos de carba-nucleósido para tratamiento antiviral
|
CA2773773C
(en)
|
2009-09-21 |
2019-04-23 |
Gilead Sciences, Inc. |
Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs
|
PE20210668A1
(es)
*
|
2009-09-21 |
2021-04-05 |
Gilead Sciences Inc |
Analogos de carba-nucleosidos sustituidos con 2'-fluoro antivirales
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US8791257B2
(en)
|
2010-03-31 |
2014-07-29 |
Bristol-Myers Squibb Company |
Substituted pyrrolotriazines as protein kinase inhibitors
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
JP5937073B2
(ja)
|
2010-07-19 |
2016-06-22 |
ギリード・サイエンシズ・インコーポレーテッド |
ジアステレオマーとして純粋なホスホルアミデートプロドラッグの調製方法
|
AU2011280910B2
(en)
*
|
2010-07-22 |
2015-07-09 |
Gilead Sciences, Inc. |
Methods and compounds for treating Paramyxoviridae virus infections
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
CA2807496C
(en)
|
2010-09-20 |
2019-01-22 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
EP2619215B1
(en)
|
2010-09-22 |
2018-09-05 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
US8754114B2
(en)
|
2010-12-22 |
2014-06-17 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
|
BR112013026219A2
(pt)
|
2011-04-13 |
2016-07-26 |
Gilead Sciences Inc |
análogos de n-nucleosídeo 1'-substituída pirimidina para tratamento antiviral
|
CA2840518A1
(en)
|
2011-07-01 |
2013-01-10 |
Bayer Intellectual Property Gmbh |
Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors
|
WO2013039920A1
(en)
|
2011-09-12 |
2013-03-21 |
Idenix Pharmaceuticals, Inc. |
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
|
CA2752008A1
(en)
|
2011-09-13 |
2013-03-13 |
Universite De Montreal |
Combination therapy using ribavirin as elf4e inhibitor
|
HUE041509T2
(hu)
|
2011-12-22 |
2019-05-28 |
Janssen Biopharma Inc |
Szubsztituált nukleozidok, nukleotidok és ezek analógjai
|
EP3932931A1
(en)
|
2012-03-13 |
2022-01-05 |
Gilead Sciences, Inc. |
A nebulizer comprising a pharmaceutical composition comprising 2'- substituted carba-nucleoside analogs for antiviral treatment
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
AR090699A1
(es)
|
2012-04-18 |
2014-12-03 |
Biocryst Pharm Inc |
Compuestos inhibidores de la actividad de la arn polimerasa viral
|
ME03300B
(me)
|
2012-06-13 |
2019-07-20 |
Incyte Holdings Corp |
Supsтituisana triciklična jedinjenja као inhibiтori fgfr
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
JP2016504284A
(ja)
*
|
2012-11-16 |
2016-02-12 |
バイオクリスト ファーマスーティカルズ,インコーポレイテッドBiocryst Pharmaceuticals,Inc. |
抗ウイルス性アザ糖を含有するヌクレオシド
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
ES2657451T3
(es)
|
2013-04-19 |
2018-03-05 |
Incyte Holdings Corporation |
Heterocíclicos bicíclicos como inhibidores del FGFR
|
US9862743B2
(en)
|
2013-10-11 |
2018-01-09 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
UA119050C2
(uk)
|
2013-11-11 |
2019-04-25 |
Ґілеад Саєнсиз, Інк. |
ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
|
WO2015143712A1
(en)
|
2014-03-28 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
4'-substituted nucleoside reverse transcriptase inhibitors
|
TWI678369B
(zh)
|
2014-07-28 |
2019-12-01 |
美商基利科學股份有限公司 |
用於治療呼吸道合胞病毒感染之噻吩並[3,2-d]嘧啶、呋喃並[3,2-d]嘧啶及吡咯並[3,2-d]嘧啶化合物類
|
TWI673283B
(zh)
|
2014-08-21 |
2019-10-01 |
美商基利科學股份有限公司 |
2’-氯胺基嘧啶酮及嘧啶二酮核苷類
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
EP3209665B1
(en)
|
2014-10-22 |
2019-08-14 |
Bristol-Myers Squibb Company |
Substituted pyrrolotriazine amine compounds as pi3k inhibitors
|
US10214537B2
(en)
|
2014-10-22 |
2019-02-26 |
Bristol-Myers Squibb Company |
Bicyclic heteroaryl amine compounds
|
TWI698444B
(zh)
*
|
2014-10-29 |
2020-07-11 |
美商基利科學股份有限公司 |
製備核糖苷的方法
|
ES2751669T3
(es)
|
2015-02-20 |
2020-04-01 |
Incyte Corp |
Heterociclos bicíclicos como inhibidores FGFR
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
US9580423B2
(en)
|
2015-02-20 |
2017-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
KR102363946B1
(ko)
|
2015-03-06 |
2022-02-17 |
아테아 파마슈티컬즈, 인크. |
HCV 치료를 위한 β-D-2'-데옥시-2'-α-플루오로-2'-β-C-치환된-2-변형된-N6-치환된 퓨린 뉴클레오티드
|
CN104876935B
(zh)
*
|
2015-05-18 |
2017-04-19 |
南方医科大学 |
2‑氨基吡咯并[1,2‑f][1,2,4]三嗪类化合物、合成方法及应用
|
PT3785717T
(pt)
|
2015-09-16 |
2022-04-14 |
Gilead Sciences Inc |
Métodos para o tratamento de infeções por coronaviridae
|
CA2998646C
(en)
|
2015-09-23 |
2021-05-18 |
Merck Sharp & Dohme Corp. |
4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof
|
WO2017155949A1
(en)
|
2016-03-09 |
2017-09-14 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Methods and kits for use in preventing and treating vulvovaginal candidiasis
|
TWI740910B
(zh)
|
2016-03-09 |
2021-10-01 |
美商艾洛斯生物製藥公司 |
非環抗病毒劑
|
SI3436461T1
(sl)
|
2016-03-28 |
2024-03-29 |
Incyte Corporation |
Pirolotriazinske spojine kot tam-inhibitorji
|
WO2018013937A1
(en)
|
2016-07-14 |
2018-01-18 |
Atea Pharmaceuticals, Inc. |
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
KR20190043602A
(ko)
|
2016-09-07 |
2019-04-26 |
아테아 파마슈티컬즈, 인크. |
Rna 바이러스 치료를 위한 2'-치환된-n6-치환된 퓨린 뉴클레오티드
|
EP3538108A4
(en)
*
|
2016-11-10 |
2020-06-17 |
Oyagen, Inc. |
METHOD FOR TREATING OR INHIBITIONING AN EBOLA VIRUS INFECTION
|
GEP20237457B
(en)
|
2017-02-01 |
2023-01-10 |
Atea Pharmaceuticals Inc |
Nucleotide hemi-sulfate salt for treatment of hepatitis c virus
|
ES2961460T3
(es)
|
2017-03-14 |
2024-03-12 |
Gilead Sciences Inc |
Métodos para tratar las infecciones por coronavirus felinas
|
AR111490A1
(es)
|
2017-05-01 |
2019-07-17 |
Gilead Sciences Inc |
Formas cristalinas de propanoato de (s)-2-etilbutil 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopirrolo[2,1-f][1,2,4]triazin-7-il)-5-ciano-3,4-dihidroxitetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)
|
CN107056775A
(zh)
*
|
2017-05-24 |
2017-08-18 |
佛山科学技术学院 |
丙型肝炎病毒ns5b聚合酶抑制剂
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
CN111093627B
(zh)
|
2017-07-11 |
2024-03-08 |
吉利德科学公司 |
用于治疗病毒感染的包含rna聚合酶抑制剂和环糊精的组合物
|
US11040975B2
(en)
|
2017-12-08 |
2021-06-22 |
Merck Sharp & Dohme Corp. |
Carbocyclic nucleoside reverse transcriptase inhibitors
|
TW202012001A
(zh)
|
2018-04-10 |
2020-04-01 |
美商亞堤製藥公司 |
C型肝炎病毒(hcv)感染硬化之患者的治療
|
JP2021523118A
(ja)
|
2018-05-04 |
2021-09-02 |
インサイト・コーポレイションIncyte Corporation |
Fgfr阻害剤の塩
|
CR20200590A
(es)
|
2018-05-04 |
2021-04-26 |
Incyte Corp |
Formas sólidas de un inhibidor de fgfr y procesos para prepararlas
|
WO2020121123A2
(en)
|
2018-12-12 |
2020-06-18 |
Janssen Biopharma, Inc. |
Cyclopentyl nucleoside analogs as anti-virals
|
US11628162B2
(en)
|
2019-03-08 |
2023-04-18 |
Incyte Corporation |
Methods of treating cancer with an FGFR inhibitor
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
IL291901A
(en)
|
2019-10-14 |
2022-06-01 |
Incyte Corp |
Bicyclyl heterocycles as fgr suppressors
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
JP2023505257A
(ja)
|
2019-12-04 |
2023-02-08 |
インサイト・コーポレイション |
Fgfr阻害剤の誘導体
|
JP2023505258A
(ja)
|
2019-12-04 |
2023-02-08 |
インサイト・コーポレイション |
Fgfr阻害剤としての三環式複素環
|
CA3163424A1
(en)
|
2020-01-27 |
2021-08-05 |
Gilead Sciences, Inc. |
Methods for treating sars cov-2 infections
|
WO2021158248A1
(en)
|
2020-02-04 |
2021-08-12 |
Oyagen, Inc. |
Method for treating coronavirus infections
|
CN113214262B
(zh)
*
|
2020-02-05 |
2023-07-07 |
华创合成制药股份有限公司 |
一种含有胍基的化合物及其制备方法和用途
|
TWI794742B
(zh)
|
2020-02-18 |
2023-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
TW202315607A
(zh)
|
2020-02-18 |
2023-04-16 |
美商基利科學股份有限公司 |
抗病毒化合物
|
WO2021168004A1
(en)
|
2020-02-18 |
2021-08-26 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
AU2021234308C1
(en)
|
2020-03-12 |
2024-02-22 |
Gilead Sciences, Inc. |
Methods of preparing 1'-cyano nucleosides
|
CN115362004A
(zh)
|
2020-04-06 |
2022-11-18 |
吉利德科学公司 |
1’-氰基取代的碳核苷类似物的吸入制剂
|
JP2023528810A
(ja)
|
2020-05-29 |
2023-07-06 |
ギリアード サイエンシーズ, インコーポレイテッド |
レムデシビル治療方法
|
EP4172160A2
(en)
|
2020-06-24 |
2023-05-03 |
Gilead Sciences, Inc. |
1'-cyano nucleoside analogs and uses thereof
|
WO2022011554A1
(zh)
*
|
2020-07-14 |
2022-01-20 |
四川大学 |
3-去氧-2-酮糖酸含氮衍生物及其制备方法和用途
|
TW202233204A
(zh)
|
2020-08-27 |
2022-09-01 |
美商基利科學股份有限公司 |
用於治療病毒感染之化合物及方法
|
US11697666B2
(en)
|
2021-04-16 |
2023-07-11 |
Gilead Sciences, Inc. |
Methods of preparing carbanucleosides using amides
|
CA3220274A1
(en)
|
2021-06-09 |
2022-12-15 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
PE20240654A1
(es)
|
2021-08-20 |
2024-04-04 |
Shionogi & Co |
Derivados de nucleosido y profarmacos de los mismos que tienen accion inhibidora del crecimiento viral
|
TW202400185A
(zh)
|
2022-03-02 |
2024-01-01 |
美商基利科學股份有限公司 |
用於治療病毒感染的化合物及方法
|